Engineering Native-like GPCR Antigens Enables Discovery of an LPA2-Blocking Antibody for Ovarian Cancer
ACS Synthetic Biology · 2026
DOI: 10.1021/acssynbio.5c00742 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Synthetic Biology, 2026. Verfasst von Jin Kim und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biopharmaceutical Chemistry, Kookmin University, Seoul 02707, Republic of Korea. Hauptthemen laut MEDLINE: Ovarian Neoplasms, Receptors, Lysophosphatidic Acid. Die Arbeit nennt 57 Literaturangaben. Gefördert von: National Research Foundation of Korea.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biopharmaceutical Chemistry, Kookmin University, Seoul 02707, Republic of Korea.
- Antibody Research Institute, Kookmin University, Seoul 02707, Republic of Korea.
- Department of Wellness-Bio Industry, Gangneung-Wonju National University, Gangneung 25457, Republic of Korea.
- Biopharmaceutical Chemistry Major School of Applied Chemistry, Kookmin University, Seoul 02707, Republic of Korea.
- Department of Marine Bio Food and Science, Gangneung-Wonju National University, Gangneung 25457, Republic of Korea.
ORCID-Profile: Tae Hyun Kang
Förderung
- National Research Foundation of Korea
Zitieren
APA
Kim, J., Shin, D. W., Lee, J., Lee, M. J., Yu, Y. G., Lee, D. H., & Kang, T. H. (2026). Engineering Native-like GPCR Antigens Enables Discovery of an LPA2-Blocking Antibody for Ovarian Cancer. ACS Synthetic Biology. https://doi.org/10.1021/acssynbio.5c00742
Vancouver
Kim J, Shin DW, Lee J, Lee MJ, Yu YG, Lee DH, et al. Engineering Native-like GPCR Antigens Enables Discovery of an LPA2-Blocking Antibody for Ovarian Cancer. ACS Synthetic Biology. 2026. doi:10.1021/acssynbio.5c00742
BibTeX
@article{Kim2026,
author = {Kim, Jin and Shin, Dong Wook and Lee, Jiyoung and Lee, Min Ji and Yu, Yeon Gyu and Lee, Dae-Hee and Kang, Tae Hyun},
title = {Engineering Native-like GPCR Antigens Enables Discovery of an LPA2-Blocking Antibody for Ovarian Cancer},
journal = {ACS Synthetic Biology},
year = {2026},
doi = {10.1021/acssynbio.5c00742}
}
EUVIMED